RP Bio Inc. (KOSDAQ:314140)
South Korea
· Delayed Price · Currency is KRW 6,740.00
+80.00 (1.20%)
At close: Mar 6, 2026
RP Bio Revenue
RP Bio had revenue of 33.22B KRW in the quarter ending September 30, 2025, with 18.21% growth. This brings the company's revenue in the last twelve months to 134.21B, up 4.65% year-over-year. In the year 2024, RP Bio had annual revenue of 123.97B, down -17.93%.
Revenue (ttm)
134.21B
Revenue Growth
+4.65%
P/S Ratio
0.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
57.20B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jin Yang Pharmaceutical | 117.19B |
| Kyung Nam Pharm | 56.18B |
| Korea Arlico Pharm | 205.21B |
| Eagle Veterinary Technology Co.,Ltd | 42.51B |
| Cosmax Nbt | 293.75B |
| Sinil Pharmaceutical | 80.97B |
| Optipharm.CO.,LTD | 21.98B |
| GeneBioTech Co. ,Ltd | 92.28B |